Trilogy Metals Enters Strategic Investment Agreement with U.S. Department of War

What Happened
Trilogy Metals Inc. announced it entered an Investment Agreement with the United States Department of War for a strategic equity investment. The Investor agreed to buy 8,215,570 units at $2.17 per unit (each unit = one common share + 0.75 warrant), generating approximately $17.8 million to Trilogy. Separately, the Investor will pay about $17.8 million to South32 Limited to buy 8,215,570 Trilogy shares from South32 and obtain a 10‑year call option on up to 6,161,678 additional shares. The combined transactions total roughly $35.6 million, which Trilogy says will be reinvested in Ambler Metals. A press release dated August 28, 2026 was furnished with the filing.

Key Details

• Trilogy will sell 8,215,570 units at $2.17 per unit (~$17.8M proceeds to Trilogy).
• Warrants: exercisable for up to 6,161,678 common shares at $0.01 per share for 10 years; exercise is conditioned on either completion of Phase 1 of the Ambler Access Road or a change of control.
• Total investor cash deployed (including payment to South32) ≈ $35.6M to be reinvested in Ambler Metals.
• Investor rights include: right to designate one independent board nominee until Oct 6, 2028, an observer right while owning ≥8,000,000 shares, information/audit rights, transfer restrictions on shares from warrant exercise, and a covenant limiting Trilogy’s borrowings above $1,000,000,000 without prior approval until Jan 1, 2029 (or change of control).
• A concurrent Cooperation Agreement among Trilogy US, South32 USA, Ambler Metals and the Investor governs cooperation on the Ambler Access Project and includes security, compliance, reporting and Restricted Entity covenants; it provides observer and inspection rights and potential special‑representative veto/tie‑breaker protections for U.S. national security reasons.
• Securities to be issued were offered exempt from registration under Section 4(a)(2); the Investor represented it is sophisticated and acquired the units for investment (no public offering).

Why It Matters
This transaction provides immediate funding tied to development of the Ambler project and brings the U.S. Department of War into a strategic investor role with governance, oversight and security-related conditions. For investors, the deal could meaningfully affect Trilogy’s capitalization and future ownership structure (potential dilution if warrants/options are exercised at $0.01 under specified triggers). The governance, information and transfer restrictions, plus the cooperation/security obligations around the Ambler Access Project, may influence how the project is permitted, financed and operated. Closing remains subject to conditions, including South32’s concurrent sale, customary closing documents and stock exchange approval.